onvuzosiran

ADARx Pharmaceuticals raises $446.3 million in upsized US IPO

ADARx Pharmaceuticals secured $446.3 million in an upsized US IPO, with AbbVie investing up to $100 million in a concurrent private placement. The San Diego-based developer plans to advance its lead c